Net Cash Provided by (Used in) Financing Activities in USD of BIOXYTRAN, INC from 2010 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Bioxytran, Inc quarterly/annual Net Cash Provided by (Used in) Financing Activities history and change rate from 2010 to Q1 2025.
  • Bioxytran, Inc Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2025 was $167K, a 67.4% increase year-over-year.
  • Bioxytran, Inc annual Net Cash Provided by (Used in) Financing Activities for 2024 was $63K, a 88.6% decline from 2023.
  • Bioxytran, Inc annual Net Cash Provided by (Used in) Financing Activities for 2023 was $550K, a 73.3% decline from 2022.
  • Bioxytran, Inc annual Net Cash Provided by (Used in) Financing Activities for 2022 was $2.06M, a 16.7% increase from 2021.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)

BIOXYTRAN, INC Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 $167K +$67K +67.4% 01 Jan 2025 31 Mar 2025 10-Q 15 May 2025
Q1 2024 $99.5K +$49.5K +99% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2025
Q1 2023 $50K -$1.33M -96.4% 01 Jan 2023 31 Mar 2023 10-Q 19 Apr 2024
Q1 2022 $1.38M +$931K +207% 01 Jan 2022 31 Mar 2022 10-Q 12 May 2023
Q1 2021 $450K +$419K +1349% 01 Jan 2021 31 Mar 2021 10-Q 23 May 2022
Q1 2020 $31.1K -$191K -86% 01 Jan 2020 31 Mar 2020 10-Q 17 May 2021
Q1 2019 $222K +$223K 01 Jan 2019 31 Mar 2019 10-Q 13 May 2020
Q1 2018 -$400 01 Jan 2018 31 Mar 2018 10-Q 15 May 2018
Q1 2016 $25K 01 Jan 2016 31 Mar 2016 10-Q 15 May 2017
Q1 2014 -$4.05K -$12.1K -150% 01 Jan 2014 31 Mar 2014 10-Q 14 May 2014
Q1 2013 $8.07K -$3.44K -29.9% 01 Jan 2013 31 Mar 2013 10-Q 14 May 2014
Q1 2012 $11.5K -$110K -90.5% 01 Jan 2012 31 Mar 2012 10-Q 15 May 2013
Q1 2011 $122K 01 Jan 2011 31 Mar 2011 10-Q/A 22 Jan 2013

BIOXYTRAN, INC Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $63K -$487K -88.6% 01 Jan 2024 31 Dec 2024 10-K 03 Apr 2025
2023 $550K -$1.51M -73.3% 01 Jan 2023 31 Dec 2023 10-K 03 Apr 2025
2022 $2.06M +$294K +16.7% 01 Jan 2022 31 Dec 2022 10-K/A 13 Jan 2025
2021 $1.77M +$784K +79.9% 01 Jan 2021 31 Dec 2021 10-K 31 Mar 2023
2020 $981K +$417K +73.9% 01 Jan 2020 31 Dec 2020 10-K 11 Apr 2022
2019 $564K +$342K +154% 01 Jan 2019 31 Dec 2019 10-K 09 Apr 2021
2018 $222K +$200K +879% 01 Jan 2018 31 Dec 2018 10-K 18 Mar 2020
2017 $22.7K -$27.3K -54.6% 01 Jan 2017 31 Dec 2017 10-K 02 Apr 2018
2016 $50K 01 Jan 2016 31 Dec 2016 10-K 02 Apr 2018
2014 $1.8K -$91.4K -98.1% 01 Jan 2014 31 Dec 2014 10-K 20 Sep 2016
2013 $93.2K +$38.4K +70.2% 01 Jan 2013 31 Dec 2013 10-K 10 Apr 2015
2012 $54.8K -$486K -89.9% 01 Jan 2012 31 Dec 2012 10-K 14 Apr 2014
2011 $541K +$402K +289% 01 Jan 2011 31 Dec 2011 10-K 15 Apr 2013
2010 $139K 01 Jan 2010 31 Dec 2010 10-K/A 31 Dec 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.